APC pathway including beta-catenin, c-MYC, and pS2 protein in intestinal type of stomach cancer

被引:0
|
作者
Chang, HK [1 ]
机构
[1] Kosin Univ, Coll Med, Dept Pathol, Pusan, South Korea
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A proposal that in normal colorectal epithelial cells, the adenomatous polyposis coli gene (APC) might modulate directly c-MYC transcription through beta-catenin/Tcf-4 was reported in 1998 (1-4). It was reported that intestinal trefoil factor (TTF) which is the same family of pS as a gastric specific tumor suppressor gene (5) is related to beta-catenin (6). Therefore, to elucidate the applicability of APC pathway in stomach and relationship between this pathway and pS2, the expressions of pS2, c-MYC, and beta-catenin proteins was evaluated by immunohistochemically in 30 cases of intestinal carcinoma of stomach which is morphologically close to colon cancer. Their immunoreactivities were 56.7% for pS2, 43.3% for c-MYC, and 86.7% for beta-catenin proteins. Interestingly, positive staining of. beta-catenin showed heterogenous pattern according to depth of invasion. Tumor cells in the invading or infiltrating edges shows strong positivity, while the tumor cells in mucosa showed loss of the expression in even same tumors. These results can indicate that in intestinal carcinoma of stomach beta-catenin involves tumor cell migration and invasion not as cell adhesion molecule but as tumor-suppressor molecule forming complex with APC.
引用
收藏
页码:339 / 342
页数:4
相关论文
共 50 条
  • [21] C-myc expression helps distinguish intestinal-type dysplasia from reactive changes in the stomach antrum
    Liang, Yuanxin
    Ciomek, Natalie
    LABORATORY INVESTIGATION, 2019, 99
  • [22] Inhibition of the association between beta-catenin and c-erbB-2 by N-terminally deleted beta-catenin suppressed the invasion and metastasis of cancer cells
    Ochiai, A
    Shibata, T
    Akimoto, S
    Hirohashi, S
    RECENT ADVANCES IN GASTROENTEROLOGICAL CARCINOGENESIS I, 1996, : 847 - 851
  • [23] CDK12 promotes papillary thyroid cancer progression through regulating the c-myc/β-catenin pathway
    Bai, Ning ss
    Fada, Xia
    Wang, Wenlong
    Lei, Yao
    Bo, Jiang
    Li, Xinying
    JOURNAL OF CANCER, 2020, 11 (15): : 4308 - 4315
  • [24] Protein kinase C mediated down-regulation of beta-catenin in colon cancer cells by doxycycline
    Veeramachaneni, NK
    Pippen, J
    Mokadam, N
    Lin, L
    Winslow, E
    Drebin, J
    ANNALS OF SURGICAL ONCOLOGY, 2003, 10 (01) : S24 - S24
  • [25] Connexin-43 facilitates breast cancer cell proliferation through upregulation of ERK-dependent beta-catenin, c-Myc and cyclin D1 expression
    Yu Shih-Feng
    Huang Tze-Sing
    CANCER RESEARCH, 2010, 70
  • [26] Beta-catenin represses protein kinase D1 gene expression by non-canonical pathway through MYC/MAX transcription complex in prostate cancer
    Nickkholgh, Bita
    Sittadjody, Sivanandane
    Rothberg, Michael B.
    Fang, Xiaolan
    Li, Kunzhao
    Chou, Jeff W.
    Hawkins, Gregory A.
    Balaji, K. C.
    ONCOTARGET, 2017, 8 (45) : 78811 - 78824
  • [27] PKM2 depletion induces the compensation of glutaminolysis through β-catenin/c-Myc pathway in tumor cells
    Wu, Haili
    Li, Zongwei
    Yang, Peng
    Zhang, Lichao
    Fan, Yongsheng
    Li, Zhuoyu
    CELLULAR SIGNALLING, 2014, 26 (11) : 2397 - 2405
  • [28] Expression of beta-catenin and its mechanism of delocalization in intestinal-type early gastric cancer based on mucin expression
    Lee, Soo Han
    Kang, Hyun Jeong
    Shin, Dong-Hun
    Cho, Duk-Yeon
    Song, Jin Mi
    Lee, Han Cheol
    Kim, Gwang Ha
    Song, Geun Am
    Sol, Mee Young
    Kim, Jee Yeon
    Choi, Kyung Un
    Lee, Chang Hun
    Huh, Gi Young
    Park, Do Youn
    HISTOLOGY AND HISTOPATHOLOGY, 2009, 24 (07) : 831 - 838
  • [29] Wnt-1、beta-catenin及C-myc在上皮性卵巢癌中的表达及意义
    胡琢瑛
    林晓
    中国妇幼保健, 2009, 24 (05) : 667 - 669
  • [30] Glucocorticoid-Inducible Kinase 2 Promotes Bladder Cancer Cell Proliferation, Migration and Invasion by Enhancing β-catenin/c-Myc Signaling Pathway
    Chen, Jin-Bo
    Zhang, Meng
    Zhang, Xiao-Long
    Cui, Yu
    Liu, Pei-Hua
    Hu, Jiao
    Li, Hui-Huang
    Jin, Hang
    Liu, Long-Fei
    Chen, Min-Feng
    Chen, He-Qun
    Liang, Chao-Zhao
    Zu, Xiong-Bing
    JOURNAL OF CANCER, 2018, 9 (24): : 4774 - 4782